메뉴 건너뛰기




Volumn 1216, Issue 35, 2009, Pages 6259-6266

Hollow fiber supported ionic liquid membrane microextraction for determination of sulfonamides in environmental water samples by high-performance liquid chromatography

Author keywords

High performance liquid chromatography; Ionic liquid; Liquid phase microextraction; Sulfonamides; Supported liquid membrane

Indexed keywords

ACCEPTOR PHASE; ANALYTES; AQUEOUS SAMPLES; BOVINE SERUM ALBUMINS; DISSOLVED ORGANIC CARBON; ENRICHMENT FACTORS; ENVIRONMENTAL WATER SAMPLES; EXTRACTION CONDITIONS; EXTRACTION EFFICIENCIES; EXTRACTION SOLVENTS; EXTRACTION TIME; HOLLOW FIBER; HUMIC ACID; LINEAR RANGE; LIQUID PHASE MICROEXTRACTION; LOW DETECTION LIMIT; MATRIX EFFECTS; MICROEXTRACTION; ORGANIC LIQUID; SALT-OUT; SPIKE RECOVERY; SULFADIMETHOXINE; SULFAMETHAZINE; SULFAMETHOXAZOLE; SULFONAMIDES; SUPPORTED IONIC LIQUID MEMBRANE; SUPPORTED LIQUID MEMBRANE; TRACE LEVEL; TRI-N-OCTYLPHOSPHINE OXIDE; ULTRA VIOLET DETECTION; VOLUME RATIO; WATER SAMPLES;

EID: 67949108060     PISSN: 00219673     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chroma.2009.06.025     Document Type: Article
Times cited : (161)

References (48)
  • 9
    • 67949109068 scopus 로고    scopus 로고
    • Guidance for Industry: Environmental Assessment of Human Drug and Biologies Applications
    • Rockville, MD, Available at, last accessed
    • US FDA, Guidance for Industry: Environmental Assessment of Human Drug and Biologies Applications. CMC 6 Revision 1. Food and Drug Administration, Rockville, MD, 1998. Available at http://www.fda.gov/cder/guidance/1730fnl.pdf (last accessed 10/19/2004).
    • (1998) CMC 6 Revision , vol.1 , pp. 10-19
    • FDA, U.1
  • 10
    • 67949119804 scopus 로고    scopus 로고
    • EMEA, Draft CPMP discussion paper on environmental risk assessment of non-genetically modified organism (non-GMO) containing medicinal products for human use. CPMP/SWP.4447/00. European Agency for the Evaluation of Medicinal Products, London, 25 January 2001.
    • EMEA, Draft CPMP discussion paper on environmental risk assessment of non-genetically modified organism (non-GMO) containing medicinal products for human use. CPMP/SWP.4447/00. European Agency for the Evaluation of Medicinal Products, London, 25 January 2001.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.